1. Home
  2. BBNX vs TBLD Comparison

BBNX vs TBLD Comparison

Compare BBNX & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • TBLD
  • Stock Information
  • Founded
  • BBNX 2015
  • TBLD 2021
  • Country
  • BBNX United States
  • TBLD United States
  • Employees
  • BBNX N/A
  • TBLD N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • TBLD Investment Managers
  • Sector
  • BBNX Health Care
  • TBLD Finance
  • Exchange
  • BBNX Nasdaq
  • TBLD Nasdaq
  • Market Cap
  • BBNX 740.7M
  • TBLD 643.6M
  • IPO Year
  • BBNX 2025
  • TBLD N/A
  • Fundamental
  • Price
  • BBNX $26.41
  • TBLD $20.24
  • Analyst Decision
  • BBNX Strong Buy
  • TBLD
  • Analyst Count
  • BBNX 10
  • TBLD 0
  • Target Price
  • BBNX $24.40
  • TBLD N/A
  • AVG Volume (30 Days)
  • BBNX 690.5K
  • TBLD 78.0K
  • Earning Date
  • BBNX 11-06-2025
  • TBLD 01-01-0001
  • Dividend Yield
  • BBNX N/A
  • TBLD 6.16%
  • EPS Growth
  • BBNX N/A
  • TBLD N/A
  • EPS
  • BBNX N/A
  • TBLD N/A
  • Revenue
  • BBNX $69,830,000.00
  • TBLD N/A
  • Revenue This Year
  • BBNX $42.80
  • TBLD N/A
  • Revenue Next Year
  • BBNX $34.58
  • TBLD N/A
  • P/E Ratio
  • BBNX N/A
  • TBLD N/A
  • Revenue Growth
  • BBNX 38911.17
  • TBLD N/A
  • 52 Week Low
  • BBNX $8.89
  • TBLD $15.80
  • 52 Week High
  • BBNX $26.66
  • TBLD $20.55
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 85.28
  • TBLD 61.82
  • Support Level
  • BBNX $18.12
  • TBLD $19.63
  • Resistance Level
  • BBNX $19.32
  • TBLD $20.10
  • Average True Range (ATR)
  • BBNX 1.35
  • TBLD 0.28
  • MACD
  • BBNX 0.75
  • TBLD 0.01
  • Stochastic Oscillator
  • BBNX 97.43
  • TBLD 81.88

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About TBLD Thornburg Income Builder Opportunities Trust

Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.

Share on Social Networks: